Bangkok, Thailand – To promote the development of medical marijuana products, U.N. member state Thailand has removed low-level cannabis and hemp extracts from its banned narcotic substances list, according to officials.
Tilray, Inc. (NASDAQ:TLRY), a global pioneer in cannabis research, cultivation, production and distribution, today announced it has entered into an agreement with Cannamedical Pharma GmbH (“Cannamedical”) through its wholly-owned subsidiary Tilray Portugal Unipessoal Lda.